Clinical Trial Update: Decompression Intervention of Variceal Rebleeding Trial (DIVERT) [Phase 3]

View source ↗

Summary

A Phase 3 trial called DIVERT assessing a decompression intervention to prevent variceal rebleeding has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Varices
• Gastric Varices
• Liver Cirrhosis

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Esophageal and Gastric Varices, Liver Cirrhosis | Phase 3 | Status: COMPLETED